+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Mammary gland tumor in transgenic mice expressing targeted beta-casein/HPV16E6 fusion gene



Mammary gland tumor in transgenic mice expressing targeted beta-casein/HPV16E6 fusion gene



International Journal of Oncology 17(6): 1093-1098



The human papillomaviruses (HPV)-16 and HPV-18 referred to as high-risk HPVs are strongly associated with anogenital malignancies as well as benign epithelial cysts. It has been demonstrated that transgenic mice carrying HPV-16 E6-E7 under the control of the MMTV LTR developed malignant tumors including salivary gland carcinoma, lymphoma, skin histiocytomas and testicular tumors in a non-mammary gland specific manner. Another regulatory unit of rat beta-casein gene can confer the expression of fusion gene preferentially in the mammary glands of transgenic mice in a developmentally regulated manner. In order to generate mammary tumor formation in transgenic mice directing HPV16E6 gene alone into the mammary gland, this regulatory unit was fused to the E6 gene of HPV-16 type to constructing fusion gene. By screening 51 newborn founder transgenic mice, three mice carrying transgenes were identified. One line termed TG32 developed in a mammary gland tumor with large subcutaneous mass in the left rib region at 17 months of age. The levels of E6 transcript in the mass-tumor of TG32 line were lower than those in non-tumor mammary gland of identical TG32 and of TG250. In each tissue of TG32 line, high expression of E6 transcript was detected both in the mammary gland and brain. Histological analysis showed that cells from mammary gland tumor of the TG32 line had also hyperplasia appearance, with irregular or increased total number of mitotic rate. These observations suggest that developing phenotype and the level of E6 transcripts in the process of malignant transformation may have different mechanisms involving the capacity to bind and destabilize p53, although for confirmation it is necessary to investigate many more transgenic mice.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010952907

Download citation: RISBibTeXText

PMID: 11078793

DOI: 10.3892/ijo.17.6.1093


Related references

Expression of a bovine beta-casein/human lysozyme fusion gene in the mammary gland of transgenic mice. Journal of Biochemistry & Molecular Biology 31(4): 413-417, July 31, 1998

Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. Proceedings of the National Academy of Sciences of the United States of America 92(17): 7849-7853, 1995

Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland. Transgenic Research 14(5): 719-727, 2005

Expression of whey acidic protein (WAP) genes in tissues other than the mammary gland in normal and transgenic mice expressing mWAP/hGH fusion gene. Molecular Reproduction and Development 41(4): 399-406, 1995

Mammary gland development in transgenic mice expressing a dominant-negative transforming growth factor-beta type II receptor under the control of the mouse mammary tumor virus promoter/enhancer. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 188, 1995

A heterologous hormone response element enhances expression of rat beta-casein promoter-driven chloramphenicol acetyltransferase fusion genes in the mammary gland of transgenic mice. Molecular Endocrinology 5(10): 1504-1512, 1991

A hybrid bovine beta-casein/bGH gene directs transgene expression to the lung and mammary gland of transgenic mice. Transgenic Research 8(4): 307-311, 2000

Production and characterization of transgenic mice expressing a hGH fusion gene driven by the promoter of mouse whey acidic protein (mWAP) putatively specific to mammary gland. Journal of Reproduction and Development 39(2): 145-155, 1993

Establishment of transgenic mice expressing c-myc gene in mammary gland. Chinese Journal of Veterinary Science 22(6): 587-589, 2002

Structure of the rabbit k-casein encoding gene: expression of the cloned gene in the mammary gland of transgenic mice. Gene 174(1 ): 34, 1996

Structure of the rabbit kappa-casein encoding gene: expression of the cloned gene in the mammary gland of transgenic mice. Gene 174(1): 27-34, 1996

Over-expressing of the bovine neonatal Fc receptor gene in the mammary gland of transgenic mice. Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006: 19-04, 2006

Structure of the rabbit kappa-casein encoding gene and expression in the mammary gland of transgenic mice. Livestock Production Science 50(1-2): 163, Oct 1, 1997

Developmental regulation of the ovine beta-lactoglobulin/human serum albumin transgene is distinct from that of the beta-lactoglobulin and the endogenous beta-casein genes in the mammary gland of transgenic mice. Developmental Genetics 16(3): 241-252, 1995

Special expression of foreign gene targeted fgfr4 in mammary gland of transgenic mice. Molecular & Cellular Proteomics 2(9): 885, September, 2003